| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.0049 | 1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.005 | 1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |